AR011105A1 - PARENTERAL LIPOSOMA FORMULATION THAT REDUCES PAIN - Google Patents
PARENTERAL LIPOSOMA FORMULATION THAT REDUCES PAINInfo
- Publication number
- AR011105A1 AR011105A1 ARP980100470A AR011105A1 AR 011105 A1 AR011105 A1 AR 011105A1 AR P980100470 A ARP980100470 A AR P980100470A AR 011105 A1 AR011105 A1 AR 011105A1
- Authority
- AR
- Argentina
- Prior art keywords
- demethyl
- deoxy
- parenteral
- liposoma
- formulation
- Prior art date
Links
Abstract
Formulaciones parenterales que reducen el dolor, que comprenden a una droga de macrolida atrapada en una vesícula de liposoma. La droga de macrolida seselecciona del grupo formado por los derivados de las eritromicinas A, B, C y D; claritromicina,azitromicina, diritromicina, josamicina, midecamicina,kitasamicina, roxitromicina, rokitamicina, oleanadomicina, miocamicina, fluritromicina, rosaramicina, 8,9-anhidro-4-deoxi-3-N-desmetil-3-N-etileritromicina B 6,9-hemiacetal,8,9-anhidro-4- deoxi-3-N-desmetil-3-N- etileritromicina A 6,9-hemiacetal, y carbamato 11,12-cíclico 11-amino-11-deoxi-3-oxo-5-O-desosaminil-6-O-[1-3-quinolil-2-propenil]-eritronoluro A. Las formulaciones son efectivas para reducirsustancialmente el dolor e n el lugarde la inyeccion típicamente asociadas con la inyeccion de antibioticos de macrolida.Parenteral pain-reducing formulations, comprising a macrolide drug trapped in a liposome vesicle. The macrolide drug is selected from the group consisting of erythromycin derivatives A, B, C, and D; clarithromycin, azithromycin, dirithromycin, josamycin, midecamycin, kitasamycin, roxithromycin, rokitamycin, oleanadomycin, myocamycin, flurithromycin, rosyramycin, 8,9-anhydro-4-deoxy-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-meme hemiacetal, 8,9-anhydro-4-deoxy-3-N-desmethyl-3-N-ethylerythromycin A 6,9-hemiacetal, and 11,12-cyclic carbamate 11-amino-11-deoxy-3-oxo-5 -O-desosaminyl-6-O- [1-3-quinolyl-2-propenyl] -eritronolide A. The formulations are effective in substantially reducing pain at the injection site typically associated with injection of macrolide antibiotics.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76406497A | 1997-02-04 | 1997-02-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR011105A1 true AR011105A1 (en) | 2000-08-02 |
Family
ID=45724859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980100470 AR011105A1 (en) | 1997-02-04 | 1998-02-03 | PARENTERAL LIPOSOMA FORMULATION THAT REDUCES PAIN |
Country Status (1)
Country | Link |
---|---|
AR (1) | AR011105A1 (en) |
-
1998
- 1998-02-03 AR ARP980100470 patent/AR011105A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2269054A1 (en) | Method of treatment of heart disease caused by chlamydia pneumoniae | |
ATE214603T1 (en) | STABLE MACROLIDES AND MACROLIDE VACCINE COMPOSITIONS | |
CA2316919A1 (en) | Novel macrolides | |
FI955913A0 (en) | New erythromycin derivatives, methods for their preparation and their use as drugs | |
FI964395A (en) | New erythromycin derivatives, method for their preparation and their use as drugs | |
BR9604880A (en) | Compound composition dosage unit form methods for administering a biologically active agent for preparing a composition for administering an active agent and for preparing a compound and pharmacological composition | |
ATE252108T1 (en) | 3'-N-OXIDE,3'-N-DIMETHYLAMINE,9-OXIMES ERYTHROMYCIN A DERIVATIVES | |
NO20001439D0 (en) | 3'-N-modified 6-O-substituted erythromycin ketolide derivatives with antibacterial activity | |
MX9304301A (en) | DERIVATIVES OF ANTIBIOTIC MACROLIDES WITH A RING OF 16 MEMBERS. | |
PT1032581E (en) | 6-O-ALKYLERITROMYCIN A CHEMICAL SYNTHETIC | |
ATE241638T1 (en) | 15-MEMBER KETOLIDE LACTAMES WITH ANTIBACTERIAL EFFECT | |
DK1004592T3 (en) | New erythromycin derivatives, their preparation and their use as drugs | |
ES526529A0 (en) | A PROCEDURE FOR THE PREPARATION OF A MACROLIDE | |
AR011105A1 (en) | PARENTERAL LIPOSOMA FORMULATION THAT REDUCES PAIN | |
ATE261425T1 (en) | ERYTHROMYCIN DERIVATIVES WITH ANTIBIOTIC ACTION | |
ATE289609T1 (en) | MACROLIDE LHRH ANTAGONISTS | |
NZ506622A (en) | 3',3'-N-bis-substituted macrolide LHRH antagonists | |
CO4920212A1 (en) | PARENTERAL FORMULATION IN LIPOSOMES FOR THE REDUCTION OF PAIN | |
ES2144154T3 (en) | DERIVATIVES OF ERYTHROMYCIN A 9-0-OXIME GIVEN WITH ANTIBIOTIC ACTIVITY. | |
FR2751656B1 (en) | NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS | |
DE69915327D1 (en) | DERIVATIVES OF ERYTHROMYCIN, CLARITHROMYCIN, ROXITHROMYCIN OR AZITHROMYCIN WITH ANTIBIOTIC AND MUCOLYTIC EFFECT | |
MX9606111A (en) | Antibiotic macrolides. | |
OA09447A (en) | New macrolide derivatives, their preparation process and the pharmaceutical compositions which contain them. | |
FR2757518B1 (en) | NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS | |
FR2792637B1 (en) | NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |